OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

2025-08-08 15:26:46 ET

OptimizeRx Corporation (OPRX)

Q2 2025 Earnings Conference Call

August 07, 2025, 04:30 PM ET

Company Participants

Andrew Jacob D'Silva - Senior Vice President of Corporate Finance

Edward Stelmakh - CFO & COO

Stephen L. Silvestro - President & CEO

Conference Call Participants

Anderson Schock - B. Riley Securities, Inc., Research Division

David Michael Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division

Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division

Jeffrey Robert Garro - Stephens Inc., Research Division

Richard Kenneth Baldry - ROTH Capital Partners, LLC, Research Division

Presentation

Operator

Good afternoon, everyone, and thank you for joining OptimizeRx's Second Quarter Fiscal 2025 Earnings Conference Call....

Read the full article on Seeking Alpha

For further details see: